Regenxbio Inc (RGNX)

SG&A Expenses

$85.56M

TTM · Period ending: · USD

RGNX logo

RGNX SG&A Expenses

Latest reported$85.56M
RGNX TTM SG&A Expenses ($3.85M → $85.56M)
High-resolution chart · PNG

RGNX sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regenxbio Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
85,555,000
83,822,000
82,863,000
80,534,000
79,703,000
78,675,000
76,619,000
75,647,000
79,308,000
84,151,000
88,494,000
90,625,000
88,463,000
85,597,000
85,281,000
86,111,000
86,220,000
83,813,000
79,333,000
74,864,000
69,693,000
66,822,000
63,817,000
60,696,000
57,239,000
55,090,000
51,815,000
48,509,000
45,115,000
40,028,000
36,850,000
30,514,000
30,950,000
28,987,000
27,229,000
28,163,000
24,919,000
24,733,000
23,590,000
22,080,000
18,447,000
15,675,000
11,912,000
8,799,000
7,302,000
4,931,000
3,849,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.